These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11498154)

  • 1. Successful therapy of acute vascular rejection with combined plasma-exchange and monoclonal antibody.
    Gupta RK; Nampoory MR; Johny KV; Costandi JN; Nair MP; Francis I; Ninan VT
    Transplant Proc; 2001 Aug; 33(5):2770-3. PubMed ID: 11498154
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.
    Lucas BA; Waid TH; Thompson JS; Brown SA; Munch LC; McKeown JW; Kryscio RJ; Prebeck RJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):543-5. PubMed ID: 8438406
    [No Abstract]   [Full Text] [Related]  

  • 3. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
    Sevmis S; Emiroglu R; Karakayali F; Yagmurdur MC; Dalgic A; Moray G; Haberal M
    Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation.
    Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
    Transplant Proc; 1998 Jun; 30(4):1170-2. PubMed ID: 9636473
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute vascular rejection in renal transplantation.
    Salmela K; von Willebrand E; Kyllönen L; Eklund B; Höckerstedt K; Isoniemi H; Krogerus L; Taskinen E; Ahonen J
    Transplant Proc; 1992 Feb; 24(1):360-1. PubMed ID: 1539318
    [No Abstract]   [Full Text] [Related]  

  • 6. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
    Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
    Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic OKT3 monoclonal antibody versus antilymphocyte globulins: a prospective, randomized study in 148 first cadaver kidney grafts.
    Broyer M; Gagnadoux MF; Guest G; Arsan A; Beurton D; Revillon Y; Niaudet P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):570-1. PubMed ID: 8438418
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasmapheresis for the treatment of acute vascular rejection in renal transplantation.
    Aichberger C; Nussbaumer W; Rosmanith P; Riedmann B; Spechtenhauser B; Feichtinger H; Fend F; Pernthaler H; Ofner D; Schönitzer D; Margreiter R
    Transplant Proc; 1997; 29(1-2):169-70. PubMed ID: 9122947
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative analysis of methyl prednisone pulse versus orthoclone therapy in the management of acute cellular rejection.
    Nampoory MR; Johny KV; Costandi JN; al-Muzairai IM; Gupta RK; Nair MP; Samhan M; al-Mousawi M
    Transplant Proc; 1997 Nov; 29(7):2967-70. PubMed ID: 9365632
    [No Abstract]   [Full Text] [Related]  

  • 10. ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation.
    Uslu A; Tokat Y; Ok E; Unsal A; Ilkgul O; Kaplan H
    Transplant Proc; 1997 Nov; 29(7):2805-6. PubMed ID: 9365571
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute kidney allograft rejection while on anti-thymocyte globulin induction: sequelae of pretransplant Alpha-Interferon treatment. a case report.
    Halim MA; Nampoory MR; Said T; Hamid MH; Nair MP; Samhan M; Al-Mousawi M; Al-Ali F; Johny KV
    Transplant Proc; 2003 Nov; 35(7):2733-4. PubMed ID: 14612097
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of OKT3 in vascular rejection.
    Schroeder TJ; Weiss MA; Smith RD; Stephens GW; First MR
    Transplantation; 1991 Feb; 51(2):312-5. PubMed ID: 1899731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Living unrelated kidney transplantation.
    Malaise J; Mourad M; Besse T; Jamar F; Baldi A; Setola P; De Meyer M; Pirson Y; Squifflet JP
    Transplant Proc; 1997 Nov; 29(7):2770-2. PubMed ID: 9365556
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between Banff classification acute rejection scores and reversal of rejection.
    Park KK; Kim HC; Kwon JK; Park SB; Cho WH
    Transplant Proc; 1998 Nov; 30(7):3067-8. PubMed ID: 9838351
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between Banff classification, acute renal rejection scores, and reversal of rejection.
    Gaber LW; Moore LW; Alloway RR; Flax S; Gaber AO
    Transplant Proc; 1995 Feb; 27(1):1019. PubMed ID: 7878784
    [No Abstract]   [Full Text] [Related]  

  • 16. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.
    Kong JM; Jeong JH; Kang JK; Seong IG; Kim BC
    Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed use of OKT3 for severe acute tubular necrosis in renal transplantation.
    VanderWerf BA
    Transplant Proc; 1996 Aug; 28(4):2115-6. PubMed ID: 8769172
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of adjusted-dose vs standard-dose OKT3 therapy of acute rejection in pediatric kidney transplant recipients.
    Piatosa B; Grenda R; Prokurat S
    Transplant Proc; 1993 Aug; 25(4):2574. PubMed ID: 8356675
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab for humoral rejection after kidney transplantation: an update.
    Rostaing L; Guilbeau-Frugier C; Kamar N
    Transplantation; 2009 Apr; 87(8):1261. PubMed ID: 19384176
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of acute kidney allograft rejection with the nonmitogenic CD3 mAb CLB T3/4.A (IgA-CD3): absence of a correlation of clinical responsiveness with inhibition of lymphocyte reactivity in vitro.
    Meijer RT; Yong SL; Surachno S; ten Berge IJ; Schellekens PT
    Transplant Proc; 2001; 33(1-2):1229-30. PubMed ID: 11267271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.